These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25438766)

  • 1. Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.
    Roth A; Ott S; Farber KM; Palazzo TA; Conrad WE; Haddadin MJ; Tantillo DJ; Cross CE; Eiserich JP; Kurth MJ
    Bioorg Med Chem; 2014 Nov; 22(22):6422-9. PubMed ID: 25438766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Davis-Beirut Reaction: a novel entry into 2H-indazoles and indazolones. Recent biological activity of indazoles.
    Haddadin MJ; Conrad WE; Kurth MJ
    Mini Rev Med Chem; 2012 Oct; 12(12):1293-300. PubMed ID: 23092440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Davis-Beirut reaction: N1,N2-disubstituted-1H-indazolones via 1,6-electrophilic addition to 3-alkoxy-2H-indazoles.
    Conrad WE; Fukazawa R; Haddadin MJ; Kurth MJ
    Org Lett; 2011 Jun; 13(12):3138-41. PubMed ID: 21612219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic method for assaying the halogenating activity of myeloperoxidase based on reaction of celestine blue B with taurine halogenamines.
    Sokolov AV; Kostevich VA; Kozlov SO; Donskyi IS; Vlasova II; Rudenko AO; Zakharova ET; Vasilyev VB; Panasenko OM
    Free Radic Res; 2015 Jun; 49(6):777-89. PubMed ID: 25790937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Davis-Beirut Reaction: Diverse Chemistries of Highly Reactive Nitroso Intermediates in Heterocycle Synthesis.
    Zhu JS; Haddadin MJ; Kurth MJ
    Acc Chem Res; 2019 Aug; 52(8):2256-2265. PubMed ID: 31328502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorination of N-acetyltyrosine with HOCl, chloramines, and myeloperoxidase-hydrogen peroxide-chloride system.
    Drabik G; Naskalski JW
    Acta Biochim Pol; 2001; 48(1):271-5. PubMed ID: 11440179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
    Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
    J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.
    Aldib I; Soubhye J; Zouaoui Boudjeltia K; Vanhaeverbeek M; Rousseau A; Furtmüller PG; Obinger C; Dufrasne F; Nève J; Van Antwerpen P; Prévost M
    J Med Chem; 2012 Aug; 55(16):7208-18. PubMed ID: 22793255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping myeloperoxidase to identify its promiscuity properties using docking and molecular dynamics simulations.
    Ramírez-Durán LA; Rosales-Hernández MC; Hernández-Rodríguez M; Mendieta-Wejebe JE; Trujillo-Ferrara J; Correa-Basurto J
    Curr Pharm Des; 2013; 19(12):2204-15. PubMed ID: 23016839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties.
    Qian S; He T; Wang W; He Y; Zhang M; Yang L; Li G; Wang Z
    Bioorg Med Chem; 2016 Dec; 24(23):6194-6205. PubMed ID: 27769672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of chemical features of potent myeloperoxidase inhibitors.
    Soubhye J; Meyer F; Furtmüller P; Obinger C; Dufrasne F; Antwerpen PV
    Future Med Chem; 2016 Jul; 8(11):1163-77. PubMed ID: 27402298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing 2H-Indazoles as Templates for SGK1, Tie2, and SRC Kinase Inhibitors.
    Schoene J; Gazzi T; Lindemann P; Christmann M; Volkamer A; Nazaré M
    ChemMedChem; 2019 Aug; 14(16):1514-1527. PubMed ID: 31264364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum.
    Boon AC; Hawkins CL; Coombes JS; Wagner KH; Bulmer AC
    Free Radic Biol Med; 2015 Sep; 86():259-68. PubMed ID: 26057938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors.
    Soubhye J; Prévost M; Van Antwerpen P; Zouaoui Boudjeltia K; Rousseau A; Furtmüller PG; Obinger C; Vanhaeverbeek M; Ducobu J; Néve J; Gelbcke M; Dufrasne FO
    J Med Chem; 2010 Dec; 53(24):8747-59. PubMed ID: 21090682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes.
    Vogt W
    Immunobiology; 1996 Aug; 195(3):334-46. PubMed ID: 8877407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oxazolo[3,2-b]indazole route to 1H-indazolones.
    Oakdale JS; Solano DM; Fettinger JC; Haddadin MJ; Kurth MJ
    Org Lett; 2009 Jul; 11(13):2760-3. PubMed ID: 19505119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-derived long-lived oxidants in cystic fibrosis sputum.
    Witko-Sarsat V; Delacourt C; Rabier D; Bardet J; Nguyen AT; Descamps-Latscha B
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1910-6. PubMed ID: 8520754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates.
    Forbes LV; Sjögren T; Auchère F; Jenkins DW; Thong B; Laughton D; Hemsley P; Pairaudeau G; Turner R; Eriksson H; Unitt JF; Kettle AJ
    J Biol Chem; 2013 Dec; 288(51):36636-47. PubMed ID: 24194519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification.
    Van Antwerpen P; Prévost M; Zouaoui-Boudjeltia K; Babar S; Legssyer I; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J; Dufrasne F
    Bioorg Med Chem; 2008 Feb; 16(4):1702-20. PubMed ID: 18063373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypochlorous acid-mediated protein oxidation: how important are chloramine transfer reactions and protein tertiary structure?
    Pattison DI; Hawkins CL; Davies MJ
    Biochemistry; 2007 Aug; 46(34):9853-64. PubMed ID: 17676767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.